Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Federal Medicaid Cuts
  • Generic Drugs
  • High-Deductible Plans
  • Gun Violence Trauma
  • Hospital Nutrition

WHAT'S NEW

  • Federal Medicaid Cuts
  • Generic Drugs
  • High-Deductible Plans
  • Gun Violence Trauma
  • Hospital Nutrition

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Oct 16 2024

Full Issue

GLP-1 Drugs Linked With Lower Risk Of Suicidal Thoughts Among Juveniles

Researchers found that 1.4% of adolescents on weight loss medications had a suicide attempt or ideation, compared with 2.3% of children who weren’t taking the medicines. Separately, anxiety is found to be more likely in firstborn and only children.

CNN: Adolescents Treated For Obesity With GLP-1 Drugs Had Lower Risk Of Suicidal Thoughts, Study Finds 

A review of the medical records of thousands of adolescents treated for obesity found that kids who received the GLP-1 medications semaglutide or liraglutide were less likely to have suicidal thoughts or attempts than those treated with behavioral interventions. The study of about 7,000 children between ages 12 and 18, published this week in the journal JAMA Pediatrics, showed that the medicines were associated with a 33% lower risk over a year. (Tirrell, 10/15)

Axios: Firstborn And Only Children Likelier To Have Anxiety

Firstborn and only children are likelier to develop anxiety and depression by the time they reach age 8 than children who are born second or later, according to a new review of almost 182,500 cases. (Bettelheim, 10/16)

If you need help —

Dial 988 for 24/7 support from the Suicide & Crisis Lifeline. It's free and confidential.

More health and wellness news —

The Hill: Coca-Cola Recalls 'Zero Sugar' Lemonade After It's Found To Contain Full Sugar

Coca-Cola has recalled thousands of cans of Minute Maid Zero Sugar Lemonade that were improperly labeled and actually contained the regular formula of lemonade with 40 grams of sugar, according to the Food and Drug Administration (FDA). The recall, which Coca-Cola issued in September but didn’t announce publicly, applied to 13,152 cases, each with 12 cartons of 12 cans of 12 ounces of lemonade. (Fortinsky, 10/15)

AP: Protesters Demand Kellogg Remove Artificial Colors From Cereals

Dozens of people rallied outside the Michigan headquarters of WK Kellogg Co. Tuesday, demanding that the company remove artificial dyes from its breakfast cereals in the U.S. Kellogg, the maker of Froot Loops and Apple Jacks, announced nearly a decade ago that it would remove artificial colors and ingredients from its products by 2018. ... On Tuesday, activists said they were delivering petitions with more than 400,000 signatures asking WK Kellogg to remove artificial dyes and BHT from their cereals. Protesters said there was evidence that artificial dyes can contribute to behavioral issues in children. (Durbin, 10/15)

KFF Health News: Listen To The Latest 'KFF Health News Minute'

“Health Minute” brings original health care and health policy reporting from the KFF Health News newsroom to the airwaves each week. (10/15)

In global health news —

The Washington Post: Brazil Transplant Patients Received Organs Infected With HIV 

Brazilian health officials are scrambling to explain how six transplant patients in the country’s well-regarded public health system received organs infected with HIV — and investigating whether there are more cases to come. The revelation has shocked this South American nation and plunged its health network, a source of national pride, into crisis. (McCoy and Dias, 10/15)

The New York Times: Therapeutic Food Shortage Puts African Children At Risk Of Starvation, U.N. Agency Says 

Nearly two million children may die of malnutrition because a product used to treat the condition is in short supply, the United Nations Children’s Fund said on Monday. Four countries — Mali, Nigeria, Niger and Chad — have exhausted their supplies of the peanut-based, high-nutrient product, called ready-to-use therapeutic food, or are on the brink of doing so. Another eight nations, including South Sudan, the Democratic Republic of Congo and Uganda, could run out by mid-2025. (Mandavilli, 10/14)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Tuesday, May 5
  • Monday, May 4
  • Friday, May 1
  • Thursday, April 30
  • Wednesday, April 29
  • Tuesday, April 28
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF